Dr. Gerald Diaz @GeraldMD
48.6M 14.2K 7.5K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
13 results
IDSA Recommendations for the Treatment of Clostridium difficile Infection in Adults
Source: https://doi.org/10.1093/cid/cix1085

#Management #Clostridium #CDifficile #IDSA2017 #Guidelines
IDSA Recommendations ... Clostridium difficile Infection ... cid/cix1085 #Management ... Clostridium #CDifficile #IDSA2017 ... #Guidelines #Adults
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Non-Intensivist Infection ... -19 Specific Medications ... #criticalcare #Guidelines ... NonIntensivist #diagnosis #management
IDSA 2017 CDiff Guidelines - TableΒ 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table ... Clostridium difficile Infection ... in Adults #Management ... Clostridium #CDifficile #IDSA2017
IDSA 2017 CDiff Guidelines - TableΒ 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Guidelines - Table ... Clostridium difficile Infection ... in Children #Management ... Clostridium #CDifficile #IDSA2017
IDSA 2017 CDiff Guidelines - TableΒ 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Clostridium difficile infection ... #Pharmacology #Management ... Clostridium #CDifficile #IDSA2017
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... respiratory tract infection ... anti-IL6 mAb) #AntiIL6 ... #Pharmacology #Management ... #Medications
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 β€’ CMV end-organ disease is best
Cytomegalovirus Infections ... ., concomitant medications ... control of the infection ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Zoster Virus (VZV) Infections ... of VZV Primary Infection ... Treatment of Varicella Infections ... Primary Varicella Infection ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 β€’
IDSA Recommendations ... #Encephalitis #IDSA ... Prevention #Treatment #opportunistic ... #infections #HIVAIDS ... #management #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis Infection ... a person with infectious ... Adolescent ARV Guidelines ... #opportunistic ... #infections #HIVAIDS